Live search
TopFind is fetching the latest matches for your search.
We reviewed 95 live results for intravenous infusion and narrowed them down to the 3 options that look most worth comparing first.
The strongest themes across this short list are Biologics and Immunosuppressants.
Sumber: Roche
Deskripsi
Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage.
Paling cocok untuk
Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access
Penilaian
Sumber: Samitivej Hospital
Deskripsi
A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy.
Paling cocok untuk
intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care
Penilaian
Sumber: National University Hospital (NUH)
Deskripsi
The Outpatient Parenteral Infusion Clinic (OPIC) at NUH provides administration of IVIg and blood products. This service is designed for stable patients with immunodeficiency, autoimmune, or neurological disorders who require regular immunoglobulin therapy in a clinical outpatient setting.
Paling cocok untuk
patients with chronic immunodeficiency, autoimmune disorder management, neurological treatment and outpatient medical care
Penilaian
| Bandingkan | Actemra Intravenous (IV) Infusion | Infliximab Infusion | Outpatient Intravenous Immunoglobulin (IVIg) Infusion |
|---|---|---|---|
| Sumber | Roche | Samitivej Hospital | National University Hospital (NUH) |
| Deskripsi | Actemra is an Interleukin-6 (IL-6) receptor antagonist containing the active ingredient tocilizumab. This intravenous formulation is used for treating moderate to severe active Rheumatoid Arthritis (RA), Polyarticular Juvenile Idiopathic Arthritis (pJIA), and Systemic Juvenile Idiopathic Arthritis (sJIA). In Thailand, it is available in 80 mg, 200 mg, and 400 mg vials (20 mg/mL), distributed through DKSH. It is a critical biologic therapy for controlling systemic inflammation and joint damage. | A biologic DMARD (TNF inhibitor) administered as an intravenous infusion (100 mg sterile powder). This service is typically provided in a hospital setting for patients with rheumatoid arthritis requiring intensive biologic therapy. | The Outpatient Parenteral Infusion Clinic (OPIC) at NUH provides administration of IVIg and blood products. This service is designed for stable patients with immunodeficiency, autoimmune, or neurological disorders who require regular immunoglobulin therapy in a clinical outpatient setting. |
| Paling cocok untuk | Rheumatoid arthritis management, Juvenile idiopathic arthritis, Hospital-based IV treatment and Thai local access | intravenous infusion therapy, biologic DMARD treatment, TNF inhibitor access and hospital-based medical care | patients with chronic immunodeficiency, autoimmune disorder management, neurological treatment and outpatient medical care |
| Tag | |||
| Aksi | Lihat detail | Lihat detail | Lihat detail |
| Penilaian |
Jika Anda ingin memulai dari opsi yang paling seimbang, saya merekomendasikan:
"Actemra Intravenous (IV) Infusion from Roche."
Saya memilih ini karena This is the primary originator brand registered and commercially available in Thailand, with established government reference pricing and local distribution.